Dengue in Vietnamese infants - Results of infection-enhancement assays correlate with age-related disease epidemiology, and cellular immune responses correlate with disease severity

Journal of Infectious Diseases

Volumn 198, Issue 4, 2008, Pages 516-524

  Chau, Tran Nguyen Bich ^a   Quyen, Nguyen Than Ha ^a   Tran, Thi Thuy ^b   Nguyen, Minh Tuan ^c   Dang, Minh Hoang ^a   Dung, Nguyen Thi Phuong ^a   Le, Bich Lien ^c   Nguyen, Thien Quy ^a   Nguyen, Trong Hieu ^d   Hieu, Lu Thi Minh ^c   Tran, Tinh Hien ^e   Nguyen, Thanh Hung ^c   Farrar, Jeremy ^a   Simmons, Cameron P ^a,f  

^a The Hospital for Tropical Diseases   (Viet Nam)

^b Children's Hospital No 2   (Viet Nam)

^c Children's Hospital No 1   (Viet Nam)

^d Hung Vuong Hospital   (Viet Nam)

^e UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^f NONE   (Viet Nam)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CHEMOKINE; CYTOKINE; HLA A ANTIGEN;

ANTIBODY DEPENDENT ENHANCEMENT; ARTICLE; CD4 LYMPHOCYTE COUNT; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CHILD; CONTROLLED STUDY; DENGUE; DENGUE VIRUS; DISEASE SEVERITY; ENZYME ASSAY; FEMALE; GROUPS BY AGE; HOSPITALIZATION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IN VIVO STUDY; INFANT; INFECTION; MAJOR CLINICAL STUDY; MALE; MATERNAL PLASMA; NATURAL KILLER CELL; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; VIET NAM;

AGE FACTORS; CD8-POSITIVE T-LYMPHOCYTES; DENGUE; DENGUE VIRUS; HLA-A ANTIGENS; HUMANS; IMMUNITY, CELLULAR; INFANT; SEVERITY OF ILLNESS INDEX;

EID: 48749095596     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/590117     Document Type: Article

References (25)

1. Guzman MG, Kouri G. Dengue: an update. Lancet Infect Dis 2002; 2:33-42.
2. Monath TP. Dengue: the risk to developed and developing countries. Proc Natl Acad Sci USA 1994; 91:2395-400.
3. Graham RR, Juffrie M, Tan R, et al. A prospective seroepidemiologic study on dengue in children four to nine years of age in Yogyakarta, Indonesia. I. Studies in 1995-1996. Am J Trop Med Hyg 1999; 61:412-9.
4. Thein S, Aung MM, Shwe TN, et al. Risk factors in dengue shock syndrome. Am J Trop Med Hyg 1997; 56:566-72.
5. Burke DS, Nisalak A, Johnson DE, Scott RM. A prospective study of dengue infections in Bangkok. Am J Trop Med Hyg 1988; 38:172- 80.
6. Sangkawibha N, Rojanasuphot S, Ahandrik S, et al. Risk factors in dengue shock syndrome: a prospective epidemiologic study in Rayong, Thailand. I. The 1980 outbreak. Am J Epidemiol 1984; 120:653-69.
7. Nguyen TH, Lei HY, Nguyen TL, et al. Dengue hemorrhagic fever in infants: a study of clinical and cytokine profiles. J Infect Dis 2004; 189:221-32.
8. Simmons CP, Chau TN, Thuy TT, et al. Maternal antibody and viral factors in the pathogenesis of dengue virus in infants. J Infect Dis 2007; 196:416-24.
9. Halstead SB, Lan NT, Myint TT, et al. Dengue hemorrhagic Fever in infants: research opportunities ignored. Emerg Infect Dis 2002; 8:1474-9.
10. Libraty DH, Endy TP, Houng HS, et al. Differing influences of virus burden and immune activation on disease severity in secondary dengue-3 virus infections. J Infect Dis 2002; 185:1213-21.
11. Vaughn DW, Green S, Kalayanarooj S, et al. Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. J Infect Dis 2000; 181:2-9.
12. Wang WK, Chen HL, Yang CF, et al. Slower rates of clearance of viral load and virus-containing immune complexes in patients with dengue hemorrhagic fever. Clin Infect Dis 2006; 43:1023-30.
13. Green S, Vaughn DW, Kalayanarooj S, et al. Early immune activation in acute dengue illness is related to development of plasma leakage and disease severity. J Infect Dis 1999; 179:755-62.
14. Juffrie M, Meer GM, Hack CE, et al. Inflammatory mediators in dengue virus infection in children: interleukin-6 and its relation to C-reactive protein and secretory phospholipase A2. Am J Trop Med Hyg 2001; 65:70-5.
15. Azeredo EL, Zagne SM, Santiago MA, et al. Characterisation of lymphocyte response and cytokine patterns in patients with dengue fever. Immunobiology 2001; 204:494-507.
16. Green S, Pichyangkul S, Vaughn DW, et al. Early CD69 expression on peripheral blood lymphocytes from children with dengue hemorrhagic fever. J Infect Dis 1999; 180:1429-35.
17. Mongkolsapaya J, Dejnirattisai W, Xu XN, et al. Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever. Nat Med 2003; 9:921-7.
18. Laoprasopwattana K, Libraty DH, Endy TP, et al. Dengue virus (DV) enhancing antibody activity in preillness plasma does not predict subsequent disease severity or viremia in secondary DV infection. J Infect Dis 2005; 192:510-9.
19. Kliks SC, Nisalak A, Brandt WE, Wahl L, Burke DS. Antibody-dependent enhancement of dengue virus growth in human monocytes as a risk factor for dengue hemorrhagic fever. Am J Trop Med Hyg 1989; 40:444-51.
20. Kliks SC, Nimmanitya S, Nisalak A, Burke DS. Evidence that maternal dengue antibodies are important in the development of dengue hemorrhagic fever in infants. Am J Trop Med Hyg 1988; 38:411-9.
21. World Health Organisation. Dengue haemorrhagic fever: diagnosis, treatment, prevention and control. Geneva: World Health Organisation, 1997.
22. Cardosa MJ, Wang SM, Sum MS, Tio PH. Antibodies against prM protein distinguish between previous infection with dengue and Japanese encephalitis viruses. BMC Microbiol 2002; 2:9.
23. Simmons CP, Popper S, Dolocek C, et al. Patterns of host genome-wide gene transcript abundance in the peripheral blood of patients with acute dengue hemorrhagic fever. J Infect Dis 2007; 195:1097-107.
24. Hombach J, Cardosa MJ, Sabchareon A, Vaughn DW, Barrett AD. Scientific consultation on immunological correlates of protection induced by dengue vaccines report from a meeting held at the World Health Organization 17-18 November 2005. Vaccine 2007; 25:4130 -9.
25. Chen JP, Lu HL, Lai SL, et al. Dengue virus induces expression of CXC chemokine ligand 10/IFN-gamma-inducible protein 10, which competitively inhibits viral binding to cell surface heparan sulfate. J Immunol 2006; 177:3185-92. 525-535